These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 25141972)

  • 1. Liver cell proliferation and tumor promotion by phenobarbital: relevance for humans?
    Braeuning A
    Arch Toxicol; 2014 Oct; 88(10):1771-2. PubMed ID: 25141972
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of hepatocyte proliferation in alpha-hexachlorocyclohexane and phenobarbital tumor promotion in B6C3F1 mice.
    Siglin JC; Weghorst CM; Klaunig JE
    Prog Clin Biol Res; 1991; 369():407-16. PubMed ID: 1719565
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver tumor promoter phenobarbital: a biphasic modulator of hepatocyte proliferation.
    Jirtle RL; Meyer SA; Brockenbrough JS
    Prog Clin Biol Res; 1991; 369():209-16. PubMed ID: 1946518
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: potential roles of early DNA damage and liver metallothionein expression.
    Chakraborty T; Chatterjee A; Rana A; Srivastawa S; Damodaran S; Chatterjee M
    Life Sci; 2007 Jul; 81(6):489-99. PubMed ID: 17651763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver tumour promotion by phenobarbital: comparison of rat and human studies.
    McLean AE; Driver HE; Sutherland IA
    Prog Clin Biol Res; 1992; 374():251-9. PubMed ID: 1320274
    [No Abstract]   [Full Text] [Related]  

  • 6. Tamoxifen induces short-term cumulative DNA damage and liver tumors in rats: promotion by phenobarbital.
    Carthew P; Martin EA; White IN; De Matteis F; Edwards RE; Dorman BM; Heydon RT; Smith LL
    Cancer Res; 1995 Feb; 55(3):544-7. PubMed ID: 7834623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a model to simulate the characteristics of rat liver tumor promotion by phenobarbital.
    Stevens FJ; Peraino C
    Carcinog Compr Surv; 1982; 7():105-9. PubMed ID: 7066914
    [No Abstract]   [Full Text] [Related]  

  • 8. Receptor-mediated hepatocarcinogenesis: role of hepatocyte proliferation and apoptosis.
    Oliver JD; Roberts RA
    Pharmacol Toxicol; 2002 Jul; 91(1):1-7. PubMed ID: 12193254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational modeling identifies key gene regulatory interactions underlying phenobarbital-mediated tumor promotion.
    Luisier R; Unterberger EB; Goodman JI; Schwarz M; Moggs J; Terranova R; van Nimwegen E
    Nucleic Acids Res; 2014 Apr; 42(7):4180-95. PubMed ID: 24464994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor formation in liver of conditional β-catenin-deficient mice exposed to a diethylnitrosamine/phenobarbital tumor promotion regimen.
    Rignall B; Braeuning A; Buchmann A; Schwarz M
    Carcinogenesis; 2011 Jan; 32(1):52-7. PubMed ID: 21047994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice.
    Moennikes O; Buchmann A; Romualdi A; Ott T; Werringloer J; Willecke K; Schwarz M
    Cancer Res; 2000 Sep; 60(18):5087-91. PubMed ID: 11016633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility.
    Bursch W; Chabicovsky M; Wastl U; Grasl-Kraupp B; Bukowska K; Taper H; Schulte-Hermann R
    Toxicol Sci; 2005 May; 85(1):515-29. PubMed ID: 15728704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenobarbital mouse liver tumors: implications of hepatic tumor promotion for cancer risk assessment.
    McClain RM
    Prog Clin Biol Res; 1995; 391():325-36. PubMed ID: 8532725
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of dieldrin and phenobarbital on preneoplastic hepatic lesion growth in male F344 rat and B6C3F1 mouse.
    Kolaja KL; Stevenson DE; Walborg EF; Klaunig JE
    Prog Clin Biol Res; 1995; 391():409-23. PubMed ID: 8532733
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications.
    Kunz W; Schaude G; Schwarz M; Tennekes H
    Carcinog Compr Surv; 1982; 7():111-25. PubMed ID: 7039825
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation between species and tissue sensitivity to chemical carcinogenesis in rodents and the induction of DNA synthesis.
    Klaunig JE; Siglin JC; Schafer LD; Hartnett JA; Weghorst CM; Olson MJ; Hampton JA
    Prog Clin Biol Res; 1991; 369():185-94. PubMed ID: 1946517
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of dose and duration of administration on the promotion index of phenobarbital in multistage hepatocarcinogenesis in the rat.
    Rizvi TA; Kennan W; Xu YH; Pitot HC
    APMIS Suppl; 1988; 2():262-74. PubMed ID: 3179034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment of test methods for examining promoters of hepatocarcinogenesis--promoting effects of phenobarbital, butylated hydroxytoluene and barbital].
    Furukawa F; Toyoda K; Kokubo T; Takahashi M; Hayashi Y
    Eisei Shikenjo Hokoku; 1984; (102):71-6. PubMed ID: 6532509
    [No Abstract]   [Full Text] [Related]  

  • 19. The increased CAR-dependent metabolism of thyroid hormones in mice with high cancer susceptibility.
    Pakharukova M; Smetanina M; Kaledin V; Obut T; Merkulova T
    Life Sci; 2010 Sep; 87(13-14):439-44. PubMed ID: 20816995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.
    Schulte-Hermann R; Timmermann-Trosiener I; Barthel G; Bursch W
    Cancer Res; 1990 Aug; 50(16):5127-35. PubMed ID: 2379175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.